Related Experiment Video
Updated: Jun 20, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Assessing the Estimands and Estimates of Hospitalization Rates in Health Economics and Clinical Medicine
Aditya Jain1, Gil Peled1, Filip Obradović1
1Department of Economics, Northwestern University, Evanston, Illinois, USA.
Abstract:
Even though data on hospital admissions are widely used in health research, hospitalization-related estimands measured using these data are not always clearly conceptualized. Consequently, estimators of these quantities can have unclear rationales and undesirable properties. We evaluate three "rate" estimators for measuring hospitalization-related estimands. Using the Grossman human capital model, we motivate the importance of measuring healthy time. We show that an upper bound on healthy time can be calculated using lengths of hospital stay without assumptions about health status outside the hospital. We illustrate the empirical value of these bounds. Next, we find that an admission rate conventionally used in clinical research is a patient follow-up time weighted average that lacks a clear basis for the weights. We propose an alternative estimator with more desirable properties and weaker assumptions. We assess its performance using a model of hospital admissions and death. Finally, we evaluate the Centers for Medicare and Medicaid Services (CMS) use of risk-standardized readmission rates to penalize hospitals by showing that risk-standardized rates can be sensitive to patient case mix, potentially leading to hospital rankings that do not reflect hospital quality. We propose treating hospital specific intercepts in the CMS risk-standardization model as a measure of quality.
Related Concept Videos
What are Estimates?
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such as the mean,...
Statistical Methods for Analyzing Epidemiological Data
Hazard Rate
Kaplan-Meier Approach
Hazard Ratio
For example, in a clinical trial evaluating a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
